The effect of diabetes on incidence and mortality in end-stage renal disease in Germany

Nephrology Dialysis Transplantation

Volumn 26, Issue 5, 2011, Pages 1634-1640

  Hoffmann, Falk ^a   Haastert, Burkhard ^b   Koch, Michael ^c,d   Giani, Guido ^d   Glaeske, Gerd ^a   Icks, Andrea ^d  

^a UNIVERSITY OF BREMEN   (Germany)

^b MediStatistica ^*  (Germany)

^c Center of Nephrology   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

diabetes; dialysis; end stage renal disease; sex; survival

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GERMANY; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS; SURVIVAL RATE;

EID: 79955601774     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq609     Document Type: Article

References (24)

1. Brancati FL, Whelton PK, Randall BL et al. Riskof end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA 1997; 278: 2069-2074 (Pubitemid 28016228)
2. Lok CE, Oliver MJ, Rothwell DM et al. The growing volume of dia-betes-related dialysis: a population based study Nephrol Dial Trans-plant 2004; 19: 3098-3103 (Pubitemid 40057634)
3. Ritz E, Rychlik I, Locatelli F et al. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 1999; 34: 795-808 (Pubitemid 29521694)
4. United States Renal Data System. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009
5. Villar E, Chang SH, McDonald SP. Incidences, treatments, outcomes, and gender effect on survival in end-stage renal disease patients by diabetic status in Australia and New Zealand (1991-2005). Diab Care 2007; 30: 3070-3076 (Pubitemid 350255248)
6. Koch M, Thomas B, Tschöpe W et al. Survival and predictorsof death in dialysed diabetic patients. Diabetologia 1993; 36: 1113-1117
7. Koch M, Hollenbeck M, Trapp R et al. Value of diabetes as an inde-pendent predictor of death in subjects with end-stage renal disease. Med Klin (Munich) 2006; 101: 933-937 (Pubitemid 46025019)
8. Metcalfe W, Khan IH, Prescott GJ et al. Scottish Renal Registry End-stage renal disease in Scotland: outcomes and standards of care. Kidney Int 2003; 64: 1808-1816 (Pubitemid 37323711)
9. Villar E, Remontet L, Labeeuw M et al. Effects of age, sex, and dia-betes on excess death in end-stage renal failure. JAm Soc Nephrol 2007; 18: 2125-2134 (Pubitemid 47041078)
10. Karame A, Labeeuw M, Trolliet P et al. The impact of type 2 diabetes on mortality in end-stage renal disease differs between genders. Nephron Clin Pract 2009; 112: c268-c275
11. Icks A, Haastert B, Trautner C et al. Incidence of lower-limb amputa-tions in the diabetic compared to the non-diabetic population. Find-ings from nationwide insurance data, Germany, 2005-2007. Exp Clin Endocrinol Diabetes 2009; 117: 500-504
12. Köster I, von Ferber L, Ihle P et al. The cost burden of diabetes mel-litus: the evidence from Germany-the CoDiM Study Diabetologia 2006; 9: 1498-1504 (Pubitemid 43848085)
13. von Ferber L, Köster I, Hauner H. Medical costs of diabetic compli-cations total costs and excess costs by age and type of treatment re-sults of the German CoDiM Study Exp Clin Endocrinol Diabetes 2007; 115: 97-104 (Pubitemid 46408116)
14. Rothman KJ. Modern Epidemiology. Boston, MA: Little, Brown and Company, 1986
15. Kleinbaum DG, Klein M. Survival Analysis: A Self-Learning Text. 2nd edn. New York: Springer, 2005
16. Icks A, Haastert B, Genz J et al. Incidence of renal replacement therapy (RRT) in the diabetic compared to the non-diabetic popula-tion in a German region, 2002-08. Nephrol Dial Transplant 2011; 26: 264-269
17. Villar E, Polkinghorne KR, Chang SH et al. Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease. Diabeto-logia 2009; 52: 2536-2541
18. Chung SH, Han DC, Noh H et al. Risk factors for mortality in diabetic peritoneal dialysis patients. Nephrol Dial Transplant 2010;25:3742-3748
19. Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract 2010; 87: 15-19
20. Jansson SP, Andersson DK, Svärdsudd K. Mortality trends in sub-jects with and without diabetes during 33 years of follow-up. Diab Care 2010; 33: 551-556
21. Icks A, Haastert B, Genz J et al. Time-dependent impact of diabetes on mortality in end-stage renal disease: a population-based study from Germany, 2002-2008. Submitted for publication
22. Icks A, Haastert B, Gandjour A et al. Costs of dialysis-a regional popu-lation-based analysis. Nephrol Dial Transplant 2010; 25: 1647-1652
23. Berger A, Edelsberg J, Inglese G et al. Identification ofpatients receiv-ing peritoneal dialysis using health insurance claims data. Clin Ther 2009;31:1321-1334
24. Schnee M, Krankenkassen SSM. Sozioökonomische Strukturen und Morbidität in den gesetzlichen Krankenkassen. In: Böcken J, Braun B, Amhof R (eds). Gesundheitsmonitor 2008. Gütersloh: Verlag Bertelsmann Stiftung, 2008; 88-104